{
  "Pharmacology": {
    "Pharmacodynamics": {
      "Mechanism of action": [
        "Serotonin Receptor Studies",
        "Prenatal Exposure",
        "Serotonin Receptor Studies",
        "Astrocyte Receptors",
        "SSRIs Effects on Dopamine Receptors",
        "Modulation of Serotonin Release by Autoreceptors and Heteroreceptors"
      ],
      "Animal Models of Disorders": [
        "Forced Swimming Test",
        "Conditioned Fear",
        "Differential Reinforcement of Low Rate (DRL) Operant Schedule",
        "Olfactory Bbulbectomized (OB) Rat Model for Depression",
        "Animal Models of Obsessive-compulsive Disorder (OCD)"
      ],
      "OtherPharmacodynamics": [
        "Neurogenesis",
        "Prenatal Exposure",
        "Ion Channels",
        "Methylenedioxymethamphetamine (MDMA) Effects on Serotonin",
        "SSRIs as Antifungal Agents",
        "SSRIs in Model Organisms ( C. Elegans and Drosophilia)",
        "Paroxetines Therapeutic Potential as G Protein-coupled Receptor Kinase 2 (GRK2) Inhibitor",
        "Loudness Dependence of Auditory Evoked Potentials (LDAEP) as Biomarker for Depression",
        "Treatment of Paroxetine Induced Sexual Dysfunction"
      ]
    },
    "Pharmacokinetics": [
      "SSRIs and the Cytochrome P450 System",
      "(Sertraline) Drug Delivery"
    ],
    "Pharmacogenetics": [
      "Serotonin Transporter Gene and Antidepressant Response",
      "Genotype Mediated Response to SSRIs"
    ],
    "Analytical Methods": [
      "Quantification of SSRIs in Biological Samples",
      "Quantification of Dopamine and Serotonin Release and Uptake"
    ],
    "Biomarker Search": [
      "Neural Processing of Emotional Cues",
      "SSRIs Effect on Brain-derived Neurotrophic Factor (BDNF) Levels in Depressive Patients"
    ],
    "OtherPharmacology": [
      "Prenatal Exposure",
      "Neural Processing of Emotional Cues",
      "SSRI Synthesis",
      "Neuroendocrine Effects of Citalopram",
      "Pharmacological Reviews",
      "Novel Compounds Synthesis and Antidepressant Potential"
    ]
  },
  "Indications": {
    "Disorders": {
      "Depression": [
        "Pediatric Depression",
        "Herbal and Natural Compounds for Depression, using Forced Swimming Test",
        "Forced Swimming Test",
        "Serotonin Transporter Gene and Antidepressant Response",
        "Fluvoxamine for Depression",
        "Sequenced Depression Treatment",
        "Depression and Cardiovascular Pathology",
        "Escitalopram for Depression",
        "SSRIs Effect on Sleep in Depressed Patients",
        "Depression in Diabetes",
        "Depression Treatment Review",
        "Depression in Epileptic Patients",
        "Depression in Parkinson's Patients",
        "Sertraline for Depression",
        "Citalopram for Depression",
        "Geriatric Depression",
        "Agomelatine for Depression",
        "SSRI Efficacy in Depression",
        "Vilazodone for Depression",
        "Depression in Hepatitis Patients",
        "SSRIs for Depression after Traumatic Brain Injury",
        "SSRIs for Depression in Cancer",
        "Transcranial Direct Current Stimulation (tDCS) for Depression",
        "Folate for Depression",
        "SSRIs for Depression in Kidney Disease Patients",
        "St. John's Wort for Depression",
        "SSRIs and Galanin in Depression",
        "SSRIs for Depression in and Treatment of Multiple Sclerosis",
        "SSRIs for Depression in Chronic Obstructive Pulmonary Disease (COPD) Patients",
        "Thyroid Hormone for Depression",
        "Olfactory Bbulbectomized (OB) Rat Model for Depression",
        "SSRIs for Depression in HIV-positive Patients",
        "SSRIs Effect on Brain-derived Neurotrophic Factor (BDNF) Levels in Depressive Patients",
        "Loudness Dependence of Auditory Evoked Potentials (LDAEP) as Biomarker for Depression",
        "Exercise for Depression",
        "Tryptophan Depletion in Depression",
        "Psychotic Depression (STOP-PD Study)",
        "SSRIs and Bariatric Surgery",
        "Methylphenidate augmentation in late-life depression",
        "SSRIs for Bipolar Depression",
        "SSRIs for Premenstrual Dysphoric Disorder (PMDD)",
        "Serotonin and Inflammation",
        "SSRIs Effect on Sleep in Depressed Patients"
      ],
      "Anxiety": [
        "Conditioned Fear",
        "SSRIs for Generalized Anxiety Disorder (GAD)",
        "SSRIs for Social Anxiety Disorder",
        "SSRIs for Pediatric Anxiety"
      ],
      "OCD": [
        "Treatment of Obsessive-Compulsive Disorder (OCD)",
        "Animal Models of Obsessive-compulsive Disorder (OCD)",
        "SSRIs for Pediatric OCD"
      ],
      "Weight and Eating Disorders": [
        "SSRIs for Weight Management",
        "SSRIs for Eating Disorders"
      ],
      "Substance Abuse": [
        "SSRIs for Alcohol Dependence",
        "SSRIs for Smoking Cessation"
      ],
      "OtherDisorders": [
        "SSRIs for PTSD",
        "SSRIs for Pain",
        "SSRIs for Panic Disorder",
        "Fluvoxamine for Covid 19",
        "Hot Flushes (Menopause)",
        "SSRIs for Dermatological Diseases",
        "Premature Ejaculation",
        "SSRIs for Irritable Bowel Disease",
        "SSRIs for Autism Spectrum Disorders",
        "SSRIs (Fluvoxamine) for Schizophrenia",
        "SSRIs for Substance Abuse (Cocaine)",
        "SSRIs for Body Dysmorphic Disorder (BDD)",
        "Pulmonary Hypertension",
        "SSRIs as Antifungal Agents",
        "SSRIs for Fibromyalgia",
        "Orofacial Pain Disorders",
        "SSRIs for Enuresis",
        "SSRIs for Migraine",
        "SSRIs for Postpartum Depression",
        "Behavioral Addictions",
        "SSRIs for Dysthymia",
        "SSRIs for Trichotillomania",
        "SSRIs for Huntington Disease",
        "SSRIs for Depression in and Treatment of Multiple Sclerosis",
        "Paroxetines Therapeutic Potential as G Protein-coupled Receptor Kinase 2 (GRK2) Inhibitor",
        "SSRIs for Syncope",
        "SSRIs for Tinnitus",
        "SSRIs for Narcolepsy",
        "SSRIs for Tourette's Syndrome",
        "Risk of Priapism"
      ]
    },
    "Special Populations": {
      "Pediatrics": [
        "Pediatric Depression",
        "SSRIs for Autism Spectrum Disorders",
        "SSRIs for Pediatric Anxiety",
        "SSRIs for Pediatric OCD"
      ],
      "Geriatrics": [
        "SSRIs in Dementias",
        "Fracture Risk",
        "SSRIs for Depression with Cognitive Impairment",
        "Depression in Parkinson's Patients",
        "Drug-Drug Interactions",
        "Hyponatremia Risk",
        "Geriatric Depression",
        "SSRIs for Depression in and Treatment of Multiple Sclerosis",
        "SSRIs and Bariatric Surgery"
      ],
      "OtherSpecialPop": [
        "Post-Stroke SSRI Use",
        "Depression and Cardiovascular Pathology",
        "Depression in Diabetes",
        "Depression in Epileptic Patients",
        "Depression in Hepatitis Patients",
        "SSRIs for Depression after Traumatic Brain Injury",
        "SSRIs for Depression in Cancer",
        "SSRIs for Depression in Kidney Disease Patients",
        "SSRIs for Depression in Chronic Obstructive Pulmonary Disease (COPD) Patients",
        "SSRIs for Depression in HIV-positive Patients",
        "SSRIs for Congenital Myasthenic Syndrome (SCCMS)"
      ]
    },
    "OtherIndications": []
  },
  "Safety": {
    "Prenatal Exposure": [
      "Prenatal Exposure",
      "Prenatal Exposure"
    ],
    "Pregnancy": [
      "Prenatal Exposure"
    ],
    "Suicide": [
      "Pediatric Depression",
      "Suicide Risk"
    ],
    "Sexual Dysfunction": [
      "Sexual Dysfunction",
      "Treatment of Paroxetine Induced Sexual Dysfunction",
      "Psilocybin for Depression"
    ],
    "Toxicity": [
      "Serotonin Syndrome",
      "Hepatotoxic Risk"
    ],
    "Bleeding Risk": [
      "Bleeding Risk"
    ],
    "Cardiovascular": [
      "QTC Prolongation"
    ],
    "OtherSafety": [
      "Fracture Risk",
      "Extrapyramidal Reactions Risk",
      "Oncopreventive and Oncolytic Properties of SSRIs",
      "Drug-Drug Interactions",
      "Hyponatremia Risk",
      "Forensic Drug Concentration",
      "SSRI Safety Reviews",
      "Withdrawal Symptoms",
      "Hyperprolactinemia-related Symptoms",
      "SRRIs Ocular Safety Risk",
      "Orofacial Pain Disorders",
      "Generic SSRIs",
      "Risk of Hallucinations",
      "Risk of Microscopic Colitis",
      "Risk of Reversible Rerebral Vasoconstriction Syndrome (RCVS)"
    ]
  },
  "OtherRoot": {
    "Drugs": {
      "Paroxetine": [
        "Paroxetine Binding",
        "Paroxetine",
        "Treatment of Paroxetine Induced Sexual Dysfunction"
      ],
      "Fluoxetine": [
        "Fluoxetine",
        "Adulterants in Weight Loss Supplements"
      ],
      "Fluoxamine": [
        "Fluvoxamine for Depression"
      ],
      "Escitalopram": [
        "Escitalopram for Depression"
      ],
      "Sertraline": [
        "Sertraline for Depression",
        "Sertraline"
      ],
      "Agomelatine": [
        "Agomelatine for Depression"
      ],
      "Vilazodone": [
        "Vilazodone for Depression"
      ],
      "Psilocybin": [
        "Methylphenidate augmentation in late-life depression"
      ]
    },
    "Ecotoxicology": [
      "Aquatic Ecotoxicology",
      "Wastewater Management"
    ],
    "Alternative Treatments": [
      "Herbal and Natural Compounds for Depression, using Forced Swimming Test",
      "Herbal and Natural Compounds for Depression"
    ],
    "Drug Utilization Patterns": [
      "SSRI Utilization Patterns",
      "Generic SSRIs"
    ],
    "Cost-Effectineness": [
      "Cost-Effectiveness"
    ],
    "Other": [
      "Personality Disorder; Learning; Behavioral Effects; Introception",
      "SSRI Use",
      "Canine Behavioral Disorders",
      "Gatways to Clinical Trials",
      "Behavioral Addictions",
      "Selective Serotonin Reuptake Inhibitors",
      "Adulterants in Weight Loss Supplements",
      "Critical Psychiatry",
      "SSRIs for Depersonalization Disorder",
      "Serotonin Modulation Effects on Primates and Rodents",
      "Risk of Reversible Rerebral Vasoconstriction Syndrome (RCVS)",
      "Gateways to Clinical Trials",
      "Citalopram Effect on Indoleamine Metabolism in Maturing Mouse Brains",
      "Depressed Infertile Women",
      "SSRIs for Olfactory reference syndrome (ORS)"
    ]
  }
}